These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 22369312)

  • 1. The combined prognostic potential of serum high-sensitivity cardiac troponin I and N-terminal pro-B-type natriuretic peptide concentrations in dogs with degenerative mitral valve disease.
    Hezzell MJ; Boswood A; Chang YM; Moonarmart W; Souttar K; Elliott J
    J Vet Intern Med; 2012; 26(2):302-11. PubMed ID: 22369312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in dogs with presumed degenerative mitral valve disease attending primary-care veterinary practices in the United Kingdom.
    Mattin MJ; Boswood A; Church DB; Brodbelt DC
    J Vet Intern Med; 2019 Mar; 33(2):432-444. PubMed ID: 30357909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma N-terminal pro-B-type natriuretic peptide concentration helps to predict survival in dogs with symptomatic degenerative mitral valve disease regardless of and in combination with the initial clinical status at admission.
    Serres F; Pouchelon JL; Poujol L; Lefebvre HP; Trumel C; Daste T; Sampedrano CC; Gouni V; Tissier R; Hawa G; Chetboul V
    J Vet Cardiol; 2009 Dec; 11(2):103-21. PubMed ID: 19850546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with disease progression in dogs with presumed preclinical degenerative mitral valve disease attending primary care veterinary practices in the United Kingdom.
    Mattin MJ; Brodbelt DC; Church DB; Boswood A
    J Vet Intern Med; 2019 Mar; 33(2):445-454. PubMed ID: 30565334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal pro B-type natriuretic peptide and left ventricular diameter independently predict mortality in dogs with mitral valve disease.
    Moonarmart W; Boswood A; Luis Fuentes V; Brodbelt D; Souttar K; Elliott J
    J Small Anim Pract; 2010 Feb; 51(2):84-96. PubMed ID: 20070494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Pimobendan on NT-proBNP and c troponin I before and after a submaximal exercise test in dogs with preclinical mitral valve disease without cardiomegaly - a randomised, double-blinded trial.
    Iwanuk N; Nolte I; Wall L; Sehn M; Raue J; Pilgram A; Rumstedt K; Bach JP
    BMC Vet Res; 2019 Jul; 15(1):237. PubMed ID: 31288807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of plasma N-terminal pro-B-type natriuretic peptide concentration with mitral regurgitation severity and outcome in dogs with asymptomatic degenerative mitral valve disease.
    Chetboul V; Serres F; Tissier R; Lefebvre HP; Sampedrano CC; Gouni V; Poujol L; Hawa G; Pouchelon J-
    J Vet Intern Med; 2009; 23(5):984-94. PubMed ID: 19572913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The diagnostic relevance of NT-proBNP and proANP 31-67 measurements in staging of myxomatous mitral valve disease in dogs.
    Wolf J; Gerlach N; Weber K; Klima A; Wess G
    Vet Clin Pathol; 2013 Jun; 42(2):196-206. PubMed ID: 23614733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal resistive index in 55 dogs with degenerative mitral valve disease.
    Chetboul V; Daste T; Gouni V; Concordet D; Trehiou-Sechi E; Serres F; Pouchelon JL; Germain CA; Layssol-Lamour C; Lefebvre HP
    J Vet Intern Med; 2012; 26(1):101-8. PubMed ID: 22111692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic variability in NT-proBNP and cardiac troponin-I in healthy dogs and dogs with mitral valve degeneration.
    Ruaux C; Scollan K; Suchodolski JS; Steiner JM; Sisson DD
    Vet Clin Pathol; 2015 Sep; 44(3):420-30. PubMed ID: 26108974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain-natriuretic peptide and cyclic guanosine monophosphate as biomarkers of myxomatous mitral valve disease in dogs.
    Moesgaard SG; Falk T; Teerlink T; Guðmundsdóttir HH; Sigurðardóttir S; Rasmussen CE; Olsen LH
    Vet J; 2011 Sep; 189(3):349-52. PubMed ID: 20822939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
    de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
    Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement.
    Stähli BE; Gebhard C; Saleh L; Falk V; Landmesser U; Nietlispach F; Maisano F; Lüscher TF; Maier W; Binder RK
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1240-7. PubMed ID: 25511571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery.
    Schouten O; Hoeks SE; Goei D; Bax JJ; Verhagen HJ; Poldermans D
    J Vasc Surg; 2009 Feb; 49(2):435-41; discussion 441-2. PubMed ID: 19028043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of Life Score as a Predictor of Death in Dogs with Degenerative Mitral Valve Disease.
    Strunz CMC; Marcondes-Santos M; Takada JY; Fragata FS; Mansur AP
    Arq Bras Cardiol; 2017 Apr; 108(4):347-353. PubMed ID: 28380134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac Troponin I and Amino-Terminal Pro B-Type Natriuretic Peptide in Dogs With Stable Chronic Kidney Disease.
    Pelander L; Häggström J; Ley CJ; Ljungvall I
    J Vet Intern Med; 2017 May; 31(3):805-813. PubMed ID: 28370332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How accurate are NT-proBNP, ANP, and cTnI levels in diagnosing dogs with myxomatous mitral valve disease?
    Chanmongkolpanit K; Riengvirodkij N; Channgam P; Kaenchan P; Buayam W; Janhirun Y; Phonarknguen R; Tansakul M; Sakcamduang W
    Open Vet J; 2024 Jun; 14(6):1426-1441. PubMed ID: 39055758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degenerative mitral valve disease: Survival of dogs attending primary-care practice in England.
    Mattin MJ; Boswood A; Church DB; McGreevy PD; O'Neill DG; Thomson PC; Brodbelt DC
    Prev Vet Med; 2015 Dec; 122(4):436-42. PubMed ID: 26058819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superior predictive value for NTproBNP compared with high sensitivity cTnT in dialysis patients: a pilot prospective observational study.
    Voroneanu L; Siriopol D; Nistor I; Apetrii M; Hogas S; Onofriescu M; Covic A
    Kidney Blood Press Res; 2014; 39(6):636-47. PubMed ID: 25571877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study.
    Eurlings LW; Sanders-van Wijk S; van Kraaij DJ; van Kimmenade R; Meeder JG; Kamp O; van Dieijen-Visser MP; Tijssen JG; Brunner-La Rocca HP; Pinto YM
    J Card Fail; 2014 Dec; 20(12):881-90. PubMed ID: 25175696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.